References
- Munoz-Price LS, Weinstein RA. Acinetobacter infection. N. Engl. J. Med.358, 1271–1281 (2008).
- Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis.42, 657–668 (2006).
- Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev. Anti Infect. Ther.6(3) 309–325 (2008).
- Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.51, 3471–3484 (2007).
- D’Costa VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science311, 374–377 (2006).
- Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet.2, e7 (2006).
- Erridge C, Moncayo-Nieto OL, Morgan R, Young M, Poxton IR. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol.56, 165–171 (2007).
- Knapp S, Wieland CW, Florquin S et al. Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med.173, 122–129 (2006).
- Renckens R, Roelofs JJ, Knapp S, de Vos AF, Florquin S, van der Poll T. The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii pneumonia. J. Infect. Dis.193, 187–195 (2006).
- van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun.75, 5597–5608 (2007).
- Vallenet D Nordmann P, Barbe V et al. Comparative analysis of acinetobacters: three genomes for three lifestyles. PLoS ONE3, e1805 (2008).
- Niu C, Clemmer KM, Bonomo RA, Rather PN. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.J. Bacteriol.190(9), 3386–3392 (2008).
- Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology149, 3473–3484 (2003).
- Lee HW, Koh YM, Kim J et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect.14, 49–54 (2008).
- Rodriguez-Bano J, Marti S, Soto S et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin. Microbiol. Infect.14, 276–278 (2008).
- Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev.21, 601–614 (2007).
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.Nat. Rev. Microbiol.5, 939–951 (2007).
- Scott P, Deye G, Srinivasan A et al. An outbreak of multidrug-resistant Acinetobacter baumannii–calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin. Infect. Dis.44, 1577–1584 (2007).
- Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977–2000. Infect. Control Hosp. Epidemiol.24, 284–295 (2003).
- Kawamura-Sato K, Wachino J, Kondo T, Ito H, Arakawa Y. Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J. Antimicrob. Chemother.61, 568–576 (2008).